ATE509944T1 - Peptidische vasopressin-rezeptoragonisten - Google Patents

Peptidische vasopressin-rezeptoragonisten

Info

Publication number
ATE509944T1
ATE509944T1 AT05783076T AT05783076T ATE509944T1 AT E509944 T1 ATE509944 T1 AT E509944T1 AT 05783076 T AT05783076 T AT 05783076T AT 05783076 T AT05783076 T AT 05783076T AT E509944 T1 ATE509944 T1 AT E509944T1
Authority
AT
Austria
Prior art keywords
receptor agonists
vasopressin receptor
peptidic vasopressin
peptidic
agonists
Prior art date
Application number
AT05783076T
Other languages
English (en)
Inventor
Kazimierz Wisniewski
Claudio Schteingart
Regent Laporte
Robert Galyean
Pierre Riviere
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of ATE509944T1 publication Critical patent/ATE509944T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
AT05783076T 2004-08-11 2005-08-03 Peptidische vasopressin-rezeptoragonisten ATE509944T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60037704P 2004-08-11 2004-08-11
EP04019029 2004-08-11
PCT/US2005/027772 WO2006020491A1 (en) 2004-08-11 2005-08-03 Peptidic vasopressin receptor agonists

Publications (1)

Publication Number Publication Date
ATE509944T1 true ATE509944T1 (de) 2011-06-15

Family

ID=34926126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05783076T ATE509944T1 (de) 2004-08-11 2005-08-03 Peptidische vasopressin-rezeptoragonisten

Country Status (26)

Country Link
US (2) US8148319B2 (de)
EP (1) EP1776133B1 (de)
JP (1) JP4664363B2 (de)
KR (1) KR100884323B1 (de)
CN (1) CN1964732B (de)
AR (1) AR050914A1 (de)
AT (1) ATE509944T1 (de)
AU (1) AU2005274070B2 (de)
BR (1) BRPI0511466B8 (de)
CA (1) CA2567797C (de)
DK (1) DK1776133T3 (de)
ES (1) ES2366702T3 (de)
HK (1) HK1100280A1 (de)
IL (1) IL178690A (de)
JO (1) JO2937B1 (de)
MX (1) MX2007001396A (de)
NO (1) NO342449B1 (de)
NZ (1) NZ550707A (de)
PL (1) PL1776133T3 (de)
PT (1) PT1776133E (de)
RU (1) RU2355701C2 (de)
SA (1) SA05260254B1 (de)
SI (1) SI1776133T1 (de)
TW (1) TWI364291B (de)
WO (1) WO2006020491A1 (de)
ZA (1) ZA200700772B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
CA2641959C (en) * 2006-02-10 2016-12-20 Ferring B.V. Novel compounds
ES2566143T3 (es) 2006-02-13 2016-04-11 Ferring B.V. Uso de agonistas peptídicos de receptor de vasopresina
US9050286B2 (en) 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists
JP5623406B2 (ja) 2008-09-17 2014-11-12 キアズマ インコーポレイテッド 医薬組成物および関連する送達方法
JO3109B1 (ar) 2012-05-10 2017-09-20 Ferring Bv منبهات لمستقبلات v1a
US9388214B2 (en) 2014-11-05 2016-07-12 Ferring B.V. V1A receptor agonists
RU2634272C1 (ru) * 2016-08-10 2017-10-24 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Композиция с дезамино-аргинин-вазотоцином для парентерального введения и способ её получения
AU2017345720B2 (en) 2016-10-21 2023-07-27 Chiasma, Inc. Terlipressin compositions and their methods of use
US11033601B2 (en) 2017-09-14 2021-06-15 The Regents Of The University Of Colorado, A Body Corporate Selective inhibition of V1b for treating fatty liver
CN109748950B (zh) * 2017-11-02 2020-10-30 深圳翰宇药业股份有限公司 一种固相合成血管升压素受体肽激动剂selepressin的方法
DK3517543T3 (da) * 2018-01-30 2020-12-07 Bachem Ag Fremstilling af glucagonpeptider
CA3119792A1 (en) 2018-11-15 2020-05-22 Ferring B.V. Compounds, compositions and methods for treating sepsis
WO2024073445A1 (en) * 2022-09-30 2024-04-04 Ocelot Bio, Inc. Mixed vasopressin receptor agonist-antagonist for modulating mean arterial pressure

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE651400A (de) 1963-04-05 1965-02-04
NL129421C (de) * 1963-08-30 1900-01-01
CS235151B1 (cs) 1982-08-26 1985-05-15 Michal Lebl Způsob dělení Dal isomerů analogů oxytocinu
US4829051A (en) 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
CS242062B1 (cs) 1984-08-23 1986-04-17 Milan Zaoral Vasopresinová a vasotocinová analoga a způsob jejich přípravy
SE457055B (sv) 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
SE469473B (sv) 1987-10-07 1993-07-12 Ferring Ab Vasoaktiva peptider
SE502644C2 (sv) 1990-02-27 1995-11-27 Ferring Ab Vasoaktiva vasotocinderivat
RU2063979C1 (ru) 1992-02-24 1996-07-20 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Пептиды последовательности окситоцина
US5516795A (en) * 1994-09-12 1996-05-14 Abbott Laboratories Heteroatom substituted propanyl derivatives having 5-lipoxygenase inhibitory activity
GB9617021D0 (en) 1996-08-13 1996-09-25 Salpep Biotechnology Inc Novel peptides for treatment of inflammation and shock
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
SE9701161D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use I
WO1999013092A1 (en) 1997-09-11 1999-03-18 The Public Health Research Institute Of The City Of New York, Inc. Enhancement of mucosal antibody responses by interleukin-6
CA2321026A1 (en) 1998-03-09 1999-09-16 Zealand Pharmaceuticals A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE0001440D0 (sv) 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
WO2002064740A2 (en) 2001-02-09 2002-08-22 Cognetix, Inc. Cone snail peptides
AU2003220919A1 (en) * 2002-03-29 2003-10-13 Wakamoto Pharmaceutical Co., Ltd. Drugs for increasing lacrimal fluid
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
WO2004030524A2 (en) 2002-10-03 2004-04-15 Pr Pharmaceuticals Treatment of autism and similar disorders
US7183255B2 (en) 2003-02-26 2007-02-27 Intradialytic Pharmaceuticals Method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
CA2641959C (en) * 2006-02-10 2016-12-20 Ferring B.V. Novel compounds
ES2566143T3 (es) * 2006-02-13 2016-04-11 Ferring B.V. Uso de agonistas peptídicos de receptor de vasopresina
JP2010513484A (ja) 2006-12-20 2010-04-30 メルク・シャープ・エンド・ドーム・コーポレイション Ｒｎａ依存性ｒｎａウイルス感染治療用ヌクレオシド環状ホスホロアミデート
RU2342949C1 (ru) 2007-03-26 2009-01-10 Юрий Георгиевич Жуковский Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя

Also Published As

Publication number Publication date
JP4664363B2 (ja) 2011-04-06
ZA200700772B (en) 2008-09-25
AR050914A1 (es) 2006-12-06
DK1776133T3 (da) 2011-07-18
TW200612976A (en) 2006-05-01
NO342449B1 (no) 2018-05-22
BRPI0511466A (pt) 2007-12-26
SI1776133T1 (sl) 2011-07-29
JO2937B1 (en) 2016-03-15
CN1964732B (zh) 2011-03-02
US20090054309A1 (en) 2009-02-26
BRPI0511466B1 (pt) 2018-01-23
CN1964732A (zh) 2007-05-16
PL1776133T3 (pl) 2011-09-30
EP1776133A1 (de) 2007-04-25
CA2567797A1 (en) 2006-02-23
MX2007001396A (es) 2007-04-19
TWI364291B (en) 2012-05-21
IL178690A (en) 2013-10-31
EP1776133A4 (de) 2008-12-31
BRPI0511466B8 (pt) 2021-05-25
WO2006020491A1 (en) 2006-02-23
US8778881B2 (en) 2014-07-15
ES2366702T3 (es) 2011-10-24
US8148319B2 (en) 2012-04-03
HK1100280A1 (en) 2007-09-14
NZ550707A (en) 2010-07-30
AU2005274070A1 (en) 2006-02-23
AU2005274070B2 (en) 2008-02-07
SA05260254B1 (ar) 2008-05-19
JP2008509221A (ja) 2008-03-27
EP1776133B1 (de) 2011-05-18
CA2567797C (en) 2012-07-10
US20120196808A1 (en) 2012-08-02
KR100884323B1 (ko) 2009-02-18
RU2007101238A (ru) 2008-09-20
NO20071314L (no) 2007-05-10
PT1776133E (pt) 2011-09-02
KR20070029183A (ko) 2007-03-13
RU2355701C2 (ru) 2009-05-20
IL178690A0 (en) 2007-02-11

Similar Documents

Publication Publication Date Title
ATE509944T1 (de) Peptidische vasopressin-rezeptoragonisten
ATE452886T1 (de) Chemokinrezeptorantagonisten
ATE382034T1 (de) Hydroisoindolin-tachykininrezeptorantagonisten
DK1844070T3 (da) Peptider med neuropeptid-2 receptor (Y2R) agonistaktivitet
ATE549350T1 (de) Neuropeptid-2-rezeptor-agonisten
DK1973886T3 (da) Prokineticin-1-receptor-antagonister
DE602005023460D1 (de) Antimykotische polypeptide
DK2653465T3 (da) Opioid-receptormodulatorer
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
DE502005001883D1 (de) Anschlussvorrichtung
ATE397618T1 (de) Peptidcyclisierung
DE602005002678D1 (de) Anschlussvorrichtung
DE602005002290D1 (de) Kraftstoffschlauch
DE502005004534D1 (de) Kämmmaschine
DK1968623T3 (da) Bacteriocin-inducer-peptider
DE502005008087D1 (de) Verbindungsvorrichtung
DE602006018334D1 (de) Indol-3-ylcarbonylazaspiroderivate als vasopressinrezeptorantagonisten
DE502005001290D1 (de) Verbindungsvorrichtung
DE502005007053D1 (de) Verbindungseinrichtung
AT500444B8 (de) Verbindungsvorrichtung
FR2871811B1 (fr) Endofucanase recombinante
DE502004004640D1 (de) Verschwenkvorrichtung
DK1735330T3 (da) Progesteronreceptormodulatorer
ITPV20040008A1 (it) Pozione
ITVI20040280A1 (it) Aerografo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1776133

Country of ref document: EP